Insider · CIK 0001707477
Mark Van Oene
Files at PACB (PACIFIC BIOSCIENCES OF CALIFORNIA, INC.). First filing Aug 20, 2025, latest Aug 18, 2026.
In brief
Mark Van Oene files SEC Form 4 as officer at PACB (PACIFIC BIOSCIENCES OF CALIFORNIA, INC.). Since Aug 20, 2025, Mark Van Oene has reported 0 open-market buys worth $0 and 4 open-market sells worth $370k, the latest filed on Aug 18, 2026.
A track record needs three past buys with six months of prices behind them; Mark Van Oene has 0, so none is measured yet.
The newest scored trade: sold $30k of PACB on Aug 17, 2026, filed Aug 18, 2026, scored 20 (weak). In the last 12 months: 0 buys worth $0 and 3 sells worth $335k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
PACB: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 20Weak | PACBsell PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | $30k 26,911 shares | -1% | +9% from low-55% from high | |
| 30Weak | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | $9,847 6,504 shares | -0% | +67% from low-43% from high | |
| 44Moderate | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | $294k 184,897 shares | -10% | +74% from low-41% from high | |
| 21Weak | PACBsell PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | $35k 26,836 shares | -1% | +46% from low-50% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Aug 17, 2026 | PACB PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | 26,911 0.01% of outstanding | $31k | Aug 17, 2026 | none |
| Mar 3, 2026 | PACB PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | 6,504 0.00% of outstanding | $9,849 | Mar 3, 2026 | $294k |
| Feb 17, 2026 | PACB PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | 303,739 0.10% of outstanding | $479k | Feb 17, 2026 | none |
| Aug 18, 2025 | PACB PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | 26,836 0.01% of outstanding | $35k | Aug 18, 2025 | none |
| Mar 3, 2025 | PACB PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | 6,486 0.00% of outstanding | $9,123 | Mar 3, 2025 | $259k |
| Feb 18, 2025 | PACB PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | 100,773 0.04% of outstanding | $189k | Feb 18, 2025 | $70k |
| Jan 10, 2025 | PACB PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | 34,405 0.01% of outstanding | $70k | Jan 10, 2025 | none |
| Mar 4, 2024 | PACB PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | 9,186 0.00% of outstanding | $45k | Mar 4, 2024 | $441k |
| Feb 16, 2024 | PACB PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | 33,560 0.01% of outstanding | $200k | Feb 16, 2024 | $241k |
| Jan 9, 2024 | PACB PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | 31,012 0.01% of outstanding | $241k | Jan 9, 2024 | none |
Transactions
Every row this insider has filed, 9 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 17, 2026 | PACB PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | SOpen-market sale Common Stock | -26,911 | $1.13 | $30k | 2,705,853 | Aug 18, 2026 |
| Aug 10, 2026 | PACB PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | AGrant or award Common Stock | +489,130 | $0.00 | $0 | 2,732,764 | Aug 11, 2026 |
| Aug 10, 2026 | PACB PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | AGrant or award Stock Option (right to buy)derivative | +1,967,888 | $0.00 | $0 | 1,967,888 | Aug 11, 2026 |
| Mar 3, 2026 | PACB PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | SOpen-market sale Common Stock | -6,504 | $1.51 | $9,847 | 2,243,634 | Mar 4, 2026 |
| Feb 27, 2026 | PACB PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | AGrant or award Common Stock | +500,000 | $0.00 | $0 | 2,242,638 | Mar 3, 2026 |
| Feb 27, 2026 | PACB PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | AGrant or award Stock Option (right to buy)derivative | +1,000,000 | $0.00 | $0 | 1,000,000 | Mar 3, 2026 |
| Feb 17, 2026 | PACB PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | SOpen-market sale Common Stock | -129,790 | $1.58 | $205k | 1,797,745 | Feb 19, 2026 |
| Feb 18, 2026 | PACB PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | SOpen-market sale Common Stock | -55,107 | $1.63 | $90k | 1,742,638 | Feb 19, 2026 |
| Aug 18, 2025 | PACB PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | SOpen-market sale Common Stock | -26,836 | $1.31 | $35k | 1,920,035 | Aug 20, 2025 |
Questions about Mark Van Oene
Answered from the filings on this page, as of the latest one.
Is Mark Van Oene buying or selling?
In the last 12 months Mark Van Oene reported 0 open-market buys worth $0 and 3 open-market sells worth $335k on SEC Form 4; the latest was sold $30k of PACB on Aug 17, 2026. Grants, option exercises and tax withholding are not counted.
How did Mark Van Oene's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Mark Van Oene has 0.
Where does Mark Van Oene file Form 4?
Mark Van Oene has filed Form 4 at PACB (PACIFIC BIOSCIENCES OF CALIFORNIA, INC.) as See Remarks. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.